Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.
Division of Laboratory Genomics, Mayo Clinic, Rochester, MN, USA.
Mod Pathol. 2018 Feb;31(2):337-342. doi: 10.1038/modpathol.2017.140. Epub 2017 Oct 6.
Giant fibrovascular polyp of the esophagus is a descriptive diagnostic term intended to encompass rare, large, polypoid esophageal masses composed of fibroadipose tissue. Despite sometimes dramatic clinical presentations, they have historically been considered to represent reactive, non-neoplastic proliferations. Recently, however, a small number of reports have described well-differentiated liposarcomas of the esophagus, mimicking giant fibrovascular polyps. In order to clarify the relationship between esophageal liposarcoma and giant fibrovascular polyp, we retrieved esophageal cases coded as 'giant fibrovascular polyp,' 'lipoma' and 'liposarcoma' from our archives and re-examined their clinicopathologic features and MDM2 amplification status. Thirteen cases were identified (lipoma (n=1), giant fibrovascular polyp (n=5), well-differentiated liposarcoma (n=3), dedifferentiated liposarcoma (n=3)). The tumors ranged from 5.2 to 19.5 cm and arose predominantly in the cervical esophagus. All consisted chiefly of mature adipose tissue, with a variable component of fibrous septa. In all cases, close inspection of these fibrous septa showed them to contain an increased number of slightly enlarged spindled cells with irregular, hyperchromatic nuclei, similar to those seen in some well-differentiated liposarcomas. Three cases, all previously classified as dedifferentiated liposarcoma, showed in addition solid zones of non-lipogenic spindle cell sarcoma. By fluorescence in situ hybridization (FISH), all cases showed MDM2 amplification, confirming diagnoses as well-differentiated (N=10) and dedifferentiated (N=3) liposarcoma. Clinical follow-up (8 cases, range 22-156 months, median 33 months) showed 3 patients with local recurrences (1 well-differentiated and 2 dedifferentiated liposarcomas), 1 patient with liver metastases (dedifferentiated liposarcoma) and 2 deaths from disease (both dedifferentiated liposarcomas). These results suggest that the great majority of large, polypoid, fat-containing masses of the esophagus represent well and dedifferentiated liposarcoma, rather than 'giant fibrovascular polyps.' We suggest that the diagnosis of 'giant fibrovascular polyp' should be made with great caution in the esophagus, and only after careful morphological study and MDM2 FISH has excluded the possibility of liposarcoma.
食管巨大纤维血管性息肉是一个描述性的诊断术语,用于描述由纤维脂肪组织组成的罕见的、大的、息肉样食管肿块。尽管这些肿块的临床表现有时很明显,但它们一直被认为是反应性的、非肿瘤性的增生。然而,最近有少数报道描述了食管分化良好的脂肪肉瘤,这些脂肪肉瘤与巨大纤维血管性息肉相似。为了阐明食管脂肪肉瘤与巨大纤维血管性息肉之间的关系,我们从我们的档案中检索了编码为“巨大纤维血管性息肉”、“脂肪瘤”和“脂肪肉瘤”的食管病例,并重新检查了它们的临床病理特征和 MDM2 扩增状态。我们共鉴定了 13 例病例(脂肪瘤 1 例,巨大纤维血管性息肉 5 例,分化良好的脂肪肉瘤 3 例,去分化脂肪肉瘤 3 例)。这些肿瘤的大小范围为 5.2 至 19.5 厘米,主要发生在颈段食管。所有肿瘤主要由成熟脂肪组织组成,伴有不同程度的纤维隔。在所有病例中,仔细观察这些纤维隔可以发现,它们含有数量增加的稍大梭形细胞,细胞核不规则、深染,类似于一些分化良好的脂肪肉瘤中的细胞。其中 3 例,之前均被归类为去分化脂肪肉瘤,另外还显示出实性非脂源性梭形细胞肉瘤区。通过荧光原位杂交(FISH),所有病例均显示 MDM2 扩增,证实诊断为分化良好(N=10)和去分化(N=3)脂肪肉瘤。临床随访(8 例,范围 22-156 个月,中位数 33 个月)显示 3 例患者出现局部复发(1 例分化良好的脂肪肉瘤和 2 例去分化脂肪肉瘤),1 例患者出现肝转移(去分化脂肪肉瘤),2 例患者死于疾病(均为去分化脂肪肉瘤)。这些结果表明,食管内大多数大的、息肉样、富含脂肪的肿块代表分化良好和去分化的脂肪肉瘤,而不是“巨大纤维血管性息肉”。我们建议在食管中应谨慎做出“巨大纤维血管性息肉”的诊断,并且只有在仔细进行形态学研究和 MDM2 FISH 排除脂肪肉瘤的可能性后才能做出诊断。